Akanda (AKAN) Non-Current Assets (2020 - 2025)
Akanda (AKAN) recorded quarterly Non-Current Assets of $2.6 million in Q2 2025, down 7.37% quarter-over-quarter from $2.9 million in Q4 2024, and up 12.61% on a YoY basis from $2.4 million in Q2 2024.
Akanda (AKAN) Non-Current Assets (2020 - 2025) Analysis & Trends
Akanda's Non-Current Assets history runs 6 years deep, the most recent figure standing at $2.6 million for Q2 2025.
- In Q2 2025, Non-Current Assets rose 12.61% year-over-year to $2.6 million; the TTM figure through Jun 2025 stood at $2.6 million (up 12.61% YoY), while the FY2024 annual figure was $2.9 million, down 59.36% from the prior year.
- Non-Current Assets was $2.6 million for Q2 2025 at Akanda, down from $2.9 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $36.5 million in Q2 2022 to a low of $2.4 million in Q2 2024.
- Historically, Non-Current Assets has averaged $15.5 million across 5 years, with a median of $5.5 million in 2021.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 765.18% in 2022, then tumbled 92.93% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $4.1 million in 2021, then jumped by 765.18% to $35.2 million in 2022, then sank by 80.0% to $7.0 million in 2023, then plunged by 59.36% to $2.9 million in 2024, then decreased by 7.37% to $2.6 million in 2025.
- The last three Non-Current Assets figures came in at $2.6 million (Q2 2025), $2.9 million (Q4 2024), and $2.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.35 Mn |
| Dec 31, 2023 | 7.03 Mn |
| Jun 30, 2023 | 33.26 Mn |
| Dec 31, 2022 | 35.18 Mn |
| Jun 30, 2022 | 36.54 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Dec 31, 2020 | 4.15 Mn |